US Firm On WIPO Budget Demands: Lisbon Must Find Funds, WIPO Financial System Must Change 05/10/2017 by Catherine Saez, Intellectual Property Watch 1 Comment World Intellectual Property Organization members this week are trying to find a compromise in order to adopt the budget for the years 2018/2019. The United States has posed conditions on approval, particularly that they would like to keep discussing a potential change in WIPO’s budget allocation to prevent the treaty they pay most into from having to fund other less financially viable treaties. They also asked that the WIPO treaty protecting geographical indications eliminate its deficit, and that no high-level negotiating meeting be provisioned for without the whole WIPO membership agreeing to it.
Medicines Law & Policy Expert Wins Prescrire Prize For ‘Major Reference Work’ On Access To Medicines 05/10/2017 by Guest contributor for Intellectual Property Watch Leave a Comment PARIS — La Revue Prescrire, a French journal for healthcare professionals, has chosen “Private Patents and Public Health” — a 2016 book written by Ellen ’t Hoen — as one of four winners of its 2017 Prescrire Prize Book Award. Calling it “a major reference work on access to medicines and the patent system,” Prescrire praised ’t Hoen’s book both for its extensive collection of data and examples as well as its readability. (Medicines Law & Policy contributor, Kaitlin Mara was the editor of the book).
Quality Of Medicines A Key Focus Of Antimicrobial Resistance Fight 05/10/2017 by William New, Intellectual Property Watch Leave a Comment NEW YORK — Assuring the quality of medicines all the way to the consumer is a key component of the global antimicrobial resistance action plan now beginning to be implemented around the world, a panel of experts said during the recent United Nations General Assembly in New York.
WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 by William New, Intellectual Property Watch 1 Comment NEW YORK — At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR.
E-Commerce Regulation Needs Harmonisation, Labour Rules Should Be Part Of Trade Laws, Panellists Say 04/10/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment As electronic commerce is on the rise, attempts to regulate it are fragmented and in need of harmonisation, according to a panel at the recent World Trade Organization Public Forum. Intellectual property could be a harmonisation tool and is a market maker, one of the panellists said. Separately, a session looked at the relationship that they said should exist between trade and labour rights, and said the way goods are produced should be taken into account in WTO rules.
New MPP-Gilead License For HIV Treatment 04/10/2017 by Intellectual Property Watch Leave a Comment The Medicines Patent Pool today announced a new licence with Gilead Sciences for a medicine which in combination with others would offer a once-daily, single-tablet HIV treatment.
WIPO Changes: New Head Of Global Health, Search On For Next Global Challenges Director 03/10/2017 by Intellectual Property Watch 1 Comment The World Intellectual Property Organization has a new head of Global Health, and the Global Challenges Division is hunting for its next director.
Canadian Universities Not Contributing Enough To Neglected Health Needs, UAEM Report Says 03/10/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The Universities Allied for Essential medicines (UAEM) evaluated 15 Canadian research-intensive universities on their contributions to biomedical research on neglected health needs, access to medicines, and education concerning access and innovation issues. The results show that for a number of those universities, this contribution is sub-optimal.
WIPO, Pharma Join Forces To Set Up Database For Medicine Procurers 03/10/2017 by Intellectual Property Watch 4 Comments Today WIPO Director General Francis Gurry and Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), signed an agreement establishing the Patent Information Initiative for Medicines, or “Pat-INFORMED,” during the General Assemblies of the Member States of WIPO taking place this week. IFPMA worked with Intellectual Property Watch to prepare a Q&A with Mr Gurry and Mr Cueni about this new initiative.
WHO Names New Leadership Team 03/10/2017 by William New, Intellectual Property Watch 1 Comment The World Health Organization today announced the new leadership team for the UN agency, with a range of geographic representation and a majority of women in the top posts.